An
antitakeover measure stipulating that
shareholders on the receiving end of a
hostile takeover may
buy shares in their own company at a
price below
fair market value. Once the
acquisition is complete, the provision allows these same shareholders to buy more shares in the new company for below market value. This forces shareholders in the acquiring company to suffer a
devaluation and
dilution of their own shares. This is done to discourage hostile takeovers among the shareholders of the acquiring companies. It is important to note that a poison pill need not use both of these tactics; sometimes it utilizes only one or the other.